574 related articles for article (PubMed ID: 21241801)
1. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons.
Calkins MJ; Reddy PH
Biochim Biophys Acta; 2011 Apr; 1812(4):507-13. PubMed ID: 21241801
[TBL] [Abstract][Full Text] [Related]
2. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease.
Calkins MJ; Manczak M; Mao P; Shirendeb U; Reddy PH
Hum Mol Genet; 2011 Dec; 20(23):4515-29. PubMed ID: 21873260
[TBL] [Abstract][Full Text] [Related]
3. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
4. Cyclophilin D deficiency rescues axonal mitochondrial transport in Alzheimer's neurons.
Guo L; Du H; Yan S; Wu X; McKhann GM; Chen JX; Yan SS
PLoS One; 2013; 8(1):e54914. PubMed ID: 23382999
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline.
Reddy PH; Manczak M; Mao P; Calkins MJ; Reddy AP; Shirendeb U
J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S499-512. PubMed ID: 20413847
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
[TBL] [Abstract][Full Text] [Related]
9. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics.
Reddy PH; Tripathi R; Troung Q; Tirumala K; Reddy TP; Anekonda V; Shirendeb UP; Calkins MJ; Reddy AP; Mao P; Manczak M
Biochim Biophys Acta; 2012 May; 1822(5):639-49. PubMed ID: 22037588
[TBL] [Abstract][Full Text] [Related]
10. Gain of PITRM1 peptidase in cortical neurons affords protection of mitochondrial and synaptic function in an advanced age mouse model of Alzheimer's disease.
Du F; Yu Q; Yan S; Zhang Z; Vangavaragu JR; Chen D; Yan SF; Yan SS
Aging Cell; 2021 May; 20(5):e13368. PubMed ID: 33951271
[TBL] [Abstract][Full Text] [Related]
11. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
[TBL] [Abstract][Full Text] [Related]
12. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease.
Reddy PH
Brain Res; 2011 Sep; 1415():136-48. PubMed ID: 21872849
[TBL] [Abstract][Full Text] [Related]
13. Amyloid beta-mediated KIF5A deficiency disrupts anterograde axonal mitochondrial movement.
Wang Q; Tian J; Chen H; Du H; Guo L
Neurobiol Dis; 2019 Jul; 127():410-418. PubMed ID: 30923004
[TBL] [Abstract][Full Text] [Related]
14. Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.
Amadoro G; Corsetti V; Atlante A; Florenzano F; Capsoni S; Bussani R; Mercanti D; Calissano P
Neurobiol Aging; 2012 Apr; 33(4):833.e1-25. PubMed ID: 21958963
[TBL] [Abstract][Full Text] [Related]
15. Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model.
Du H; Guo L; Yan S; Sosunov AA; McKhann GM; Yan SS
Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18670-5. PubMed ID: 20937894
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective Effects of Ferruginol, Jatrophone, and Junicedric Acid Against Amyloid-β Injury in Hippocampal Neurons.
Zolezzi JM; Lindsay CB; Serrano FG; Ureta RC; Theoduloz C; Schmeda-Hirschmann G; Inestrosa NC
J Alzheimers Dis; 2018; 63(2):705-723. PubMed ID: 29660932
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of AMPA receptor trafficking at hippocampal synapses by beta-amyloid oligomers: the mitochondrial contribution.
Rui Y; Gu J; Yu K; Hartzell HC; Zheng JQ
Mol Brain; 2010 Mar; 3():10. PubMed ID: 20346152
[TBL] [Abstract][Full Text] [Related]
19. Early selective vulnerability of synapses and synaptic mitochondria in the hippocampal CA1 region of the Tg2576 mouse model of Alzheimer's disease.
Balietti M; Giorgetti B; Casoli T; Solazzi M; Tamagnini F; Burattini C; Aicardi G; Fattoretti P
J Alzheimers Dis; 2013; 34(4):887-96. PubMed ID: 23313923
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.
Cai Q; Tammineni P
J Alzheimers Dis; 2017; 57(4):1087-1103. PubMed ID: 27767992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
